ArcticZymes Technologies ASA (FRA:B4V) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 09, 2026)


FRA:B4V ArcticZymes Technologies ASA FRA:B4V
78 GF Score
Price €1.66
GF Value €2.14
! 1 Warning Sign
View Full Analysis

What is ArcticZymes Technologies ASA Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

ArcticZymes Technologies ASA's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

FRA:B4V vs VRTX, REGN, ALNY: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, ArcticZymes Technologies ASA's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ArcticZymes Technologies ASA Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where ArcticZymes Technologies ASA's Margin of Safety % (DCF FCF Based) falls into.


FRA:B4V
78GF Score
ArcticZymes Technologies ASA FRA:B4V
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ArcticZymes Technologies ASA (FRA:B4V) Overvalued in 2026?

Based on GuruFocus' analysis, ArcticZymes Technologies ASA stock appears to be undervalued. The current stock price of €1.66 is trading 22.4% below its estimated GF Value™ of €2.14.

Key valuation signals for FRA:B4V:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €2.14 vs. price of €1.66 (22.4% below fair value)
  • GF Score™: 78/100 with 1 warning sign

No single metric tells the full story. See the FRA:B4V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ArcticZymes Technologies ASA Business Description

Address Sykehusveien 23, Tromso, NOR, 9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
78GF Score

Get the complete analysis for FRA:B4V

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.66
Price
€2.14
GF Value